Healthcare Triangle Inc. (HCTI)
NASDAQ: HCTI
· Real-Time Price · USD
3.72
0.42 (12.73%)
At close: Aug 15, 2025, 12:16 PM
Healthcare Triangle Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.7M | 2.19M | 2.41M | 2.98M | 4.11M | 7.06M | 7.78M | 8.53M | 9.84M | 11.29M | 11.95M | 11.59M | 11.06M | 9.19M | 8.08M | 10.05M | 7.95M |
Cost of Revenue | 3.38M | 1.93M | 1.69M | 2.09M | 3.63M | 5.53M | 6.07M | 6.58M | 8.24M | 9.48M | 8.52M | 8.43M | 8.16M | 6.92M | 5.35M | 6.7M | 5.77M |
Gross Profit | 329K | 256K | 722K | 898K | 478K | 1.53M | 1.71M | 1.95M | 1.59M | 1.81M | 3.43M | 3.16M | 2.89M | 2.27M | 2.73M | 3.35M | 2.18M |
Operating Income | -1.4M | -498K | -1.17M | -1.38M | -1.71M | -5.02M | -1.52M | -1.59M | -3.21M | -4.76M | -2.25M | -1.43M | -1.97M | -3.34M | -1.77M | 467.56K | -716K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.7M | -1.34M | -1.25M | -1.51M | -1.86M | -5.33M | -1.94M | -1.78M | -3.26M | -4.85M | -2.3M | -404K | -1.99M | -3.43M | -1.99M | 303.44K | -811K |
Net Income | -1.7M | -1.35M | -1.25M | -1.51M | -1.86M | -5.33M | -1.94M | -1.79M | -3.28M | -4.86M | -2.34M | -405K | -2.01M | -3.45M | -1.99M | 304K | -814K |
Selling & General & Admin | 1.57M | 1.19M | 1.37M | 1.53M | 2.06M | 1.6M | 2.46M | 2.64M | 3.39M | 2.9M | 3.29M | 3.1M | 3.09M | 3.34M | 2.08M | 1.85M | 1.93M |
Research & Development | 144K | -80K | 175K | 207K | 127K | 104K | 54K | 102K | 539K | 2.77M | 1.47M | 646K | 1.07M | 1.48M | 2.2M | 813.4K | 757K |
Other Expenses | 12K | -354K | 343K | 534K | n/a | 4.84M | 712K | 802K | 874K | 910K | 909K | 844K | 711K | 788.27K | 211.33K | 211.31K | 211K |
Operating Expenses | 1.73M | 754K | 1.89M | 2.28M | 2.19M | 6.55M | 3.23M | 3.54M | 4.8M | 6.58M | 5.67M | 4.59M | 4.87M | 5.61M | 4.5M | 2.88M | 2.9M |
Interest Expense | 413K | 853K | 80K | 131K | 149K | 305K | 415K | 186K | 62K | 83K | 55K | 58K | 16K | 86.89K | 220.63K | 164.12K | 95K |
Selling & Marketing Expenses | 373K | 395K | 294K | 631K | 883K | 782K | 1.1M | 1.03M | 1.76M | 1.6M | 1.81M | 1.65M | 1.74M | 1.96M | 1.33M | 804.98K | 668K |
Cost & Expenses | 5.1M | 2.69M | 3.58M | 4.36M | 5.82M | 12.08M | 9.3M | 10.12M | 13.05M | 16.05M | 14.2M | 13.02M | 13.03M | 12.53M | 9.85M | 9.58M | 8.67M |
Income Tax Expense | n/a | 4K | 2K | 1K | 5K | 7K | 4K | 5K | 19K | 12K | 37K | 1K | 21K | 19.49K | 942.00 | 734.00 | 3K |
Shares Outstanding (Basic) | 408.01M | 408.01M | 407.97M | 382.78M | 320.78M | 310.24M | 304.44M | 304.44M | 301.39M | 300.31M | 259.36M | 255.49M | 255.65M | 224.58M | 204.89M | 212.97M | 209.31M |
Shares Outstanding (Diluted) | 408.01M | 408.01M | 407.97M | 382.78M | 320.78M | 310.24M | 304.44M | 304.44M | 301.39M | 300.31M | 259.36M | 255.49M | 255.65M | 224.58M | 207.65M | 218.88M | 211.09M |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.00 | -0.01 | -0.02 | -0.01 | 0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.00 | -0.01 | -0.02 | -0.01 | 0.00 | -0.00 |
EBITDA | -1.27M | -636K | -824K | -844K | -1.17M | -176K | -812K | -793K | -2.32M | -3.86M | -1.34M | 498K | -1.26M | -2.55M | -1.56M | 678.87K | -505K |
EBIT | -1.29M | -491K | -1.17M | -1.38M | -1.71M | -5.02M | -1.52M | -1.59M | -3.2M | -4.77M | -2.25M | -346K | -1.97M | -3.34M | -1.77M | 467.56K | -716K |
Depreciation & Amortization | 12K | -145K | 343K | 534K | 536K | 4.84M | 712K | 802K | 874K | 910K | 909K | 844K | 711K | 788.27K | 211.33K | 211.31K | 211K |